Industry Experts Discuss Need for Quality Improvements in Clinical Research

The Time is Now to Professionalize the Clinical Trial Industry

“It’s a sin not to [advance] professionalization in the clinical trial industry,” Robert O’Neill, the U.S. Food and Drug Administration’s (FDA’s) senior statistical advisor for the Office of Translational Sciences in the Center for Drug Evaluation and Research, told attendees of the DIA 2018 Global Annual Meeting in Boston this week. “It’s really time.” Predicting […]